Published date: 8 July 2020
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
North East
Value of contract
£327,150
Procurement reference
1784-S
Published date
8 July 2020
Closing date
11 June 2020
Contract start date
12 June 2020
Contract end date
11 December 2020
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
CPI require a number of enzymes to use as part of its response to COVID-19 vaccine project. The Public Contract Regulations 2015 state in regulation 32.2) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:-
(ii)competition is absent for technical reasons
Requirement to use lipids provided as being used in the current manufacturing process and forms part of the technical transfer. They are a critical raw material so we therefore cannot change supplier.
Award information
Awarded date
11 June 2020
Contract start date
12 June 2020
Contract end date
11 December 2020
Total value of contract
£327,150
This contract was awarded to 1 supplier.
Acuitas Therapeutics
Address
402 - 6190 Agronomy Road
Vancouver, BC V6T 1Z3
CanadaReference
No reference - other
Value of contract
£327,150
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
CPI Procurement
Address
Wilton
REDCAR
TS104RF
England
Telephone
01740 625716
Share this notice
Closing: 11 June 2020
All content is available under the
